Innerspace - The Simulator Company is a pioneering startup in the pharmaceutical industry, offering a solution to enhance the training and assessment of cleanroom personnel. With the slogan, "Innerspace helps leading pharmaceutical manufacturers to effectively train and assess cleanroom personnel," the company has set a clear mission to improve the efficiency and reduce the risks associated with cleanroom operations.
Founded in 2017 and headquartered in Austria, Innerspace has garnered significant attention in the investment landscape, culminating in their latest milestone - a €5.70M Seed Round investment on 01 February 2024. This substantial injection of funds was made possible through the support of prominent investors including aws Gründerfonds, Matterwave Ventures, MAD Ventures GmbH, and HTGF | High-Tech Gruenderfonds.
The company's description highlights its innovative approach, utilizing a risk-based training methodology drawing on learning psychology and state-of-the-art virtual reality technology. Innerspace's modules are tailored to align with the latest revision of Annex 1, ensuring compliance and aiming to minimize human error, ultimately leading to risk reduction, cost savings, and quality assurance for pharmaceutical organizations.
This recent investment is a testament to the faith of the investor community in Innerspace's vision and the potential impact of their solution on the pharmaceutical industry.